Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6729 |
Lomibuvir
VX-222,VCH-222 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Lomibuvir (VCH-222) (VX-222) 是丙型肝炎病毒 NS5B 聚合酶的一种非核苷变构抑制剂,Kd 值为 17 nM,已证明具有临床疗效。Lomibuvir 抑制 1b/Con1 型 HCV 亚基因组复制子,EC50为 5.2 nM。Lomibuvir 优先抑制延长的 RNA 合成,而非从头合成的 RNA。 | |||
T3489 |
Dasabuvir
ABT-333,达塞布韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dasabuvir (ABT-333) 是丙型肝炎病毒非结构蛋白 5B 的非核苷抑制剂,是一种 RNA 依赖性 RNA 聚合酶,具有抗 HCV 的潜在活性。 | |||
T28762 |
Setrobuvir
RO-5466731,ANA-598,RG7790,ANA598,RG-7790 |
HCV Protease; SARS-CoV; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
Setrobuvir (ANA-598) 是一种口服活性非核苷类HCV NS5B 聚合酶抑制剂,对新的RNA 合成和引物延伸具有抑制作用,IC50s 在4到5nM 之间。Setrobuvir 对SARS-CoV-2 RdRp 显示出很好的结合亲和力,能诱导RdRp 受到抑制。 | |||
T21537L |
TMC647055 Choline Hydroxide Salt
TMC647055 Choline Hydroxide Salt (1204416-97-6 free base) |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
TMC647055 Choline Hydroxide Salt 是一种新型有效的 HCV NS5B 聚合酶非核苷抑制剂,可用于治疗 HCV 感染。它具有纳摩尔级细胞效力(EC(50) 为 82 nM),相关细胞毒性较小(CC(50)>20 μM),在大鼠和狗中具有良好的药代动力学特征。 TMC647055 显示出有体外生化、动力学和病毒学特征的前景。 | |||
T31369 |
Deleobuvir
BI207127,BI-207127,BI 207127,BI-207127NA |
||
Deleobuvir(BI207127) is an inhibitor of non-nucleoside hepatitis C virus NS5B polymerase for the treatment of hepatitis C. | |||
T15631 | JTK-853 | Others | Others |
JTK-853 is a novel, non-nucleoside inhibitor of Hepatitis C Virus (HCV) polymerase. It also displays effective antiviral activity in HCV replicon cells (EC50s: 0.38 and 0.035 µM in genotype 1a H77 and 1b Con1 strains, respectively). | |||
T38510 | ABT-072 potassium trihydrate | ||
ABT-072, also known as potassium trihydrate, is a highly effective non-nucleoside inhibitor of the HCV NS5B polymerase, administered orally. This compound exhibits potent activity against HCV GT1a (with an EC50 of 1 nM) and HCV GT1b (with an EC50 of 0.3 nM). | |||
T62160 |
AS-136A
|
||
AS-136A 是一种麻疹病毒 RNA 依赖性 RNA 聚合酶(RdRp)的、口服具有活力的非核苷抑制剂,能够作用于麻疹病毒 (IC50: 2 μM)。 | |||
T63593 |
Dasabuvir sodium
|
||
Dasabuvir (ABT-333) sodium 是非核苷丙型肝炎病毒 (HCV) 聚合酶抑制剂。Dasabuvir sodium 对 HCV NS5B 基因编码的 RNA 依赖性 RNA 聚合酶 (RNA polymerase) 表现出抑制作用。Dasabuvir sodium 能够抑制基因型 1a (菌株 H77) 复制子 (EC50: 7.7 nM) 和 1b (菌株 Con1) 复制子 (EC50: 1.8 nM)。 | |||
T35533 |
6-Hydroxypyridin-3-ylboronic Acid
|
||
6-Hydroxypyridin-3-ylboronic acid is a heterocyclic building block.1,2It has been used in the synthesis of non-nucleoside inhibitors of hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B).16-Hydroxypyridin-3-ylboronic acid has also been used in the synthesis of mammalian target of rapamycin (mTOR) inhibitors.2 1.Hendricks, R.T., Spencer, S.R., Blake, J.F., et al.3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymeraseBioorg. Med. Chem. Lett.1... | |||
T74516 | CI-39 | ||
CI-39 是一种抗病毒天然产物。CI-39 是一种 NNRTI (非核苷类逆转录酶抑制) 抗病毒剂,对野生型HIV 的EC50为 3.40 µM,CC50>30 µM。CI-39 抑制HIV-1RT DNA 聚合酶和核糖核酸酶 H 活性。 | |||
T70846 |
Deleobuvir sodium
|
||
Deleobuvir sodium is the salt form of Deleobuvir, also known as BI207127, a non-nucleoside hepatitis C virus NS5B polymerase inhibitor for the treatment of hepatitis C. Deleobuvir was tested in combination regimens with pegylated interferon and ribavirin, and in interferon-free regimens with other direct-acting antiviral agents including faldaprevir. Deleobuvir showed that a triple combination of deleobuvir, faldaprevir, and ribavirin performed well in HCV genotype 1b patients. Efficacy fell b... | |||
T69657 | GS-441524 HCl | ||
GS-441524 is a potent inhibitor of feline infectious peritonitis (FIP) virus with an EC50 of 0.78 μM.. GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. GS-441524 is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule. These analogs act as an alternative substrate and RNA-chain terminator of viral RNA dependent RNA polymerase. GS-441524 was non-toxic in feline cells at concentrations ... | |||
T73814 |
cis-Lomibuvir
|
||
cis-Lomibuvir (cis-VX-222) 是 Lomibuvir 的顺式异构体。Lomibuvir (VX-222) 是一种选择性的非核苷聚合酶抑制剂,靶向丙型肝炎病毒 NS5B 聚合酶 (RdRp) 的拇指口袋 2,Kd 为 17 nM。Lomibuvir 抑制 1b/Con1 型 HCV 亚基因组复制子,EC50为 5.2 nM。Lomibuvir 优先抑制延长的 RNA 合成,而非从头合成的 RNA。 |